Dysregulation of cholesterol metabolism in cancer progression
- 29 September 2023
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 42 (45) , 3289-3302
Abstract
Cholesterol homeostasis has been implicated in the regulation of cellular and body metabolism. Hence, deregulated cholesterol homeostasis leads to the development of many diseases such as cardiovascular diseases, and neurodegenerative diseases, among others. Recent studies have unveiled the connection between abnormal cholesterol metabolism and cancer development. Cholesterol homeostasis at the cellular level dynamically circulates between synthesis, influx, efflux, and esterification. Any dysregulation of this dynamic process disrupts cholesterol homeostasis and its derivatives, which potentially contributes to tumor progression. There is also evidence that cancer-related signals, which promote malignant progression, also regulate cholesterol metabolism. Here, we described the relationship between cholesterol metabolism and cancer hallmarks, with particular focus on the molecular mechanisms, and the anticancer drugs that target cholesterol metabolism.Keywords
This publication has 153 references indexed in Scilit:
- Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer developmentBreast Cancer Research, 2013
- Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanismBreast Cancer Research, 2013
- Anticancer Activity of the Cholesterol Exporter ABCA1 GeneCell Reports, 2012
- p53 and cancer stem cells: The mevalonate connexionCell Cycle, 2012
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate PathwayCell, 2012
- An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent PathwayCancer Discovery, 2011
- Role of Cholesterol in the Development and Progression of Breast CancerThe American Journal of Pathology, 2011
- Spatiotemporal Analysis of Differential Akt Regulation in Plasma Membrane MicrodomainsMolecular Biology of the Cell, 2008
- SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell GrowthCell Metabolism, 2008
- The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cellsBiochemical and Biophysical Research Communications, 2007